Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk

Radiotherapy and Oncology

Volumn 88, Issue 1, 2008, Pages 77-87

  Fenoglietto, Pascal ^a   Laliberte, Benoit ^b   Allaw, Ali ^a   Ailleres, Norbert ^a   Idri, Katia ^a   Hay, Meng Huor ^a   Moscardo, Carmen Llacer ^a   Gourgou, Sophie ^a   Dubois, Jean Bernard ^a   Azria, David ^a  

^a CENTRE VAL D AURELLE   (France)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Conformal radiotherapy; Intensity modulated radiotherapy; Organ motion; Prostate cancer; Treatment planning

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; ORGAN SIZE; PATIENT POSITIONING; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URINARY BLADDER;

EID: 45849116936     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.011     Document Type: Article

References (43)

1. Hanks G.E., Leibel S.A., Krall J.M., et al. Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 11 (1985) 153-157
2. Hanks G.E., Martz K.L., and Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 15 (1988) 1299-1305
3. Smit W.G., Helle P.A., van Putten W.L., et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 18 (1990) 23-29
4. Nguyen L.N., Pollack A., Zagars G.K., et al. Late effects after radiotherapy for prostate cancer in a randomized-dose-response study: results of a self-assessment questionnaire. Urology 51 (1998) 991-997
5. Sandler H.M., Perez-Tamayo C., Ten Haken R.K., et al. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 23 (1992) 53-54
6. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41 (1998) 501-510
7. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
8. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 94-06. Int J Radiat Oncol Biol Phys 46 (2000) 391-402
9. Ryu J.K., Winter K., Michalski J.M., et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 54 (2002) 1036-1046
10. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353 (1999) 267-272
11. Koper P.C., Stroom J.C., van Putten W.L., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 43 (1999) 727-734
12. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy vs 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
13. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
14. Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
15. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs highdose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
16. Burman C., Chui C.S., Kutchek G., et al. Planning, delivery and quality assurance of IMRT using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 39 (1997) 863-873
17. Teh B.S., Woo S.Y., Butler E.B., et al. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist 4 (1999) 433-442
18. De Meerleer G.O., Vakaet L.A., De Gersem W.R.T., et al. Radiotherapy of prostate cancer with or without IMRT: a planning comparison. Int J Radiat Oncol Biol Phys 47 (2000) 639-648
19. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
20. Ailleres N., Azria D., Thezenas S., et al. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer. Cancer Radiother 8 (2004) 59-69
21. Teh B.S., Woo S.Y., Mai W.Y., et al. Clinical experience with IMRT for prostate cancer with the use of a rectal balloon for prostate immobilization. Med Dosim 27 (2002) 105-113
22. De Meerleer G.O., Fonteyne V.H., Vakaet L., et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 82 (2007) 160-166
23. Zelefsky M.J., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1419
24. Jani A.B., Su A., Correa D., et al. Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields. Prostate Cancer Prostatic Dis 10 (2007) 82-86
25. Chen M.J., Weltman E., Hanriot R.M., et al. Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?. Radiat Oncol 2 (2007) 6
26. Langen K.M., and Jones D.T.L. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
27. Bey P., Carrie C., Beckendorf V., et al. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer - preliminary results. Int J Radiat Oncol Biol Phys 48 (2000) 513-517
28. Beckendorf V., Guerif S., Le Prise E., et al. The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1056-1065
29. Ghilezan M., Yan D., Lianfg J., et al. Online image-guided intensity-modulated radiotherapy for prostate cancer: how much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60 (2004) 1602-1610
30. Wachter S., Gerstner N., Dorner D., et al. The influence of rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 91-100
31. Nijkamp J., Pos F., Nuver T., et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys 70 (2008) 75-82
32. Heemsbergen W.D., Hoogeman M.S., Witte M.G., et al. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the dutch trial of 68 Gy versus 78 Gy. Int J Radiat Oncol Biol Phys 67 (2007) 1418-1424
33. De Crevoisier R., Tucker S.L., Dong L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 965-973
34. Boersma L.J., van Den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
35. Kopera P.C., Jansena P., van Puttena W., et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol 73 (2004) 1-9
36. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321
37. Tucker S.L., Cheung R., Dong L., et al. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 353-365
38. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 55 (2003) 688-694
39. Tucker S.L., Dong L., Cheung R., et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modelling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1589-1601
40. Peeters S.T.H., Lebesque J.V., Heemsbergen W.D., et al. Localised volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
41. Happersetta L., Magerasa G., Zelefsky M.J., et al. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. Radiother Oncol 66 (2003) 263-270
42. Zelefsky M.J., Crean D., Mageras G.S., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50 (1999) 225-234
43. Landoni V., Saracino B., Marzi S., et al. A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. Int J Radiat Oncol Biol Phys 65 (2006) 587-594